Identification of novel TMPRSS2:ERG mechanisms in prostate cancer metastasis: involvement of MMP9 and PLXNA2. (Q39147275)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Identification of novel TMPRSS2:ERG mechanisms in prostate cancer metastasis: involvement of MMP9 and PLXNA2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json

Martine Duterque-Coquillaud

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

N Tomavo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

L Huot

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

A Flourens

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

E Bonnelye

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

S Flajollet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

X Leroy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Y de Launoit

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

English

0 references

publication date

27 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

2204-2214

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Prostate cancer as a model system for genetic diversity in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Common gene rearrangements in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Role of the TMPRSS2-ERG gene fusion in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

A causal role for ERG in neoplastic transformation of prostate epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

A transcriptional repressor co-regulatory network governing androgen response in prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Evidence of Independent Origin of Multiple Tumors From Patients With Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Multifocal prostate cancer: biologic, prognostic, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

End points and outcomes in castration-resistant prostate cancer: from clinical trials to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

The transcription factor SPDEF suppresses prostate tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Tyrosine phosphorylation in semaphorin signalling: shifting into overdrive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Semaphorin signaling in cancer cells and in cells of the tumor microenvironment--two sides of a coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Plexin-B1 mutations in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Matrix metalloproteinases and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Delineation of prognostic biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

The mutational landscape of lethal castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

The impact of translocations and gene fusions on cancer causation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

The relationship of TMPRSS2-ERG gene fusion between primary and metastatic prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

ERG rearrangement metastasis patterns in locally advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Tumor metastasis: molecular insights and evolving paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Matrix metalloproteinases: regulators of the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Ets-1 regulates TNF-alpha-induced matrix metalloproteinase-9 and tenascin expression in primary bronchial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

ETS1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-refractory PC3 prostate cancer cells by up-regulating MDR1 and MMP9 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

A role for class 3 semaphorins in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Effect of cancer-associated mutations in the PlexinB1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

The Ets family member Erg gene is expressed in mesodermal tissues and neural crests at fundamental steps during mouse embryogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Repulsive and attractive semaphorins cooperate to direct the navigation of cardiac neural crest cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Mesodermal expression of the chicken erg gene associated with precartilaginous condensation and cartilage differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Identification of four alternatively spliced transcripts of the Ucma/GRP gene, encoding a new Gla-containing protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

RREB-1 is a transcriptional repressor of HLA-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Diversity of TMPRSS2-ERG fusion transcripts in the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

Marked heterogeneity of ERG expression in large primary prostate cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.176

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23708657%20AND%20SRC:MED&resulttype=core&format=json